Seer, Inc. Class A SEER 深 沪
已收盘 02-06 16:00:00 美东时间
1.79
+0.040
+2.29%
华盛通- 最 高1.805
- 今 开1.78
- 成交量 8.76万股
- 最 低 1.78
- 昨 收 1.75
- 总市值 1.01亿
- 52周最高 2.41
- 市盈率 静 --
- 换手率 0.16%
- 52周最低 1.62
- 委 比 14.50%
- 总股本 5625.15万
- 历史最高 86.55
- 量 比 0.39
- 振 幅 1.43%
- 历史最低 1.455
- 每 手 1
- 风险率 0.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Salesforce Stock Hits New 52-Week Lows: Could MrBeast Save Things With Super Bowl Commercial?
Could a Super Bowl commercial help rescue the falling Salesforce stock price? What if its an idea from leading content creator MrBeast?
02-07 22:31
FTSE Russell proposes cutting free‑float bar to lure foreign firms
FTSE Russell proposes cutting free‑float bar to lure foreign firms LONDON, Jan 27 (Reuters) - FTSE Russell, the index provider, is considering lowering to 10% the minimum free‑float requirement for foreign‑incorporated companies listed in London in one of its FTSE UK benchmarks . The cut from the cu
01-27 19:29
BigBear.ai Acquires CargoSeer Technologies for AI-Powered Customs Solutions
BigBear.ai Acquires CargoSeer Technologies for AI-Powered Customs Solutions BigBear.ai has acquired certain technologies from CargoSeer, an AI software company specializing in cargo scanning enhancement and trade risk management for customs enforcement. CargoSeer's AI Shipment Inspection Platform us
01-22 05:15
Dave Inc. Appoints Nima Khajehnouri to Board of Directors; Announces Board Leadership Transitions
Dave Inc., a leading neobank, announced that Nima Khajehnouri, a prominent AI and data engineering leader, has joined its Board of Directors. Khajehnouri, currently Vice President of Engineering at Meta, brings over two decades of experience at major tech companies including Google and Snap. His appointment follows a strategic effort to enhance Dave's technical leadership and innovation. Imran Khan, who joined the Board in August 2023, is steppin...
01-20 22:27
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
Seer, Inc. announced new data at the Human Proteome Organization (HUPO) World Congress 2025, showcasing how its Proteograph Product Suite is advancing research in cardiovascular, oncology, and aging biology. The company highlighted over a dozen scientific presentations, including two invited talks and sixteen posters, demonstrating the platform's scalability and impact in translational and population-scale studies. Omid Farokhzad, CEO, emphasized...
2025-11-07 12:00
Seer to Participate in Upcoming November Investor Conferences
Seer, Inc. announced that its management will participate in two upcoming investor conferences: the UBS Global Healthcare Conference on November 12th and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 20th. Live webcasts and archived replays of the sessions will be available on Seer’s Investor website. Seer, a leader in deep, unbiased proteomics, offers advanced solutions for biological insights through...
2025-10-29 20:05
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
Seer, Inc. will participate in the ASHG 2025 Annual Meeting, showcasing how its Proteograph Product Suite enhances multi-omic translational studies and identifies protein isoform-specific biomarkers. The company will host a CoLab session, "Advancing Precision Medicine Through Multi-Omics," featuring insights from xenotransplantation and fibrosis research. Additionally, independent studies using Seer’s platform will demonstrate its role in integra...
2025-10-10 11:00
SEERai™ by Galorath Wins SiliconANGLE TechForward Award with Industry-First Agentic Artificial Intelligence
SEERai Recognized as the Industry's First Agentic AI Platform Transforming Cost, Schedule, and Risk Planning in Secure Enterprise Environments LONG BEACH, Calif., Sept. 16, 2025 /PRNewswire/...
2025-09-16 18:15
Seer Appoints Isaac Ro to its Board of Directors
Seer, Inc. has appointed Isaac Ro to its Board of Directors. Ro, known for his financial leadership and extensive experience in life sciences and healthcare, brings valuable expertise to Seer as it continues to advance its proteomics platform. Ro currently serves as a Partner at Catalio Capital Management and has a proven track record of guiding companies through transformative growth. His appointment reflects Seer's commitment to expanding its i...
2025-09-02 11:00
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Seer, Inc. (Nasdaq: SEER) announced its participation in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York. Seer’s management will engage in a fireside chat on September 9th at 12:20 p.m. Eastern Time / 9:20 a.m. Pacific Time. A live webcast will be available on Seer’s Investor webpage, with an archived replay following the event. Seer is a leader in unbiased proteomics, offering scalable and precise solutions throu...
2025-08-26 20:05
